Kala Bio, Inc. (KALA)
0.613
-0.04
(-5.55%)
USD |
NASDAQ |
Jan 09, 16:00
0.6211
+0.01
(+1.32%)
After-Hours: 18:10
Kala Bio Total Assets (Quarterly): 25.02M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Q32 Bio, Inc. | 57.78M |
| PharmaCyte Biotech, Inc. | 55.98M |
| Allogene Therapeutics, Inc. | 439.77M |
| Belite Bio, Inc. | 282.39M |
| CEL-SCI Corp. | 28.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.69M |
| Shareholders Equity (Quarterly) | -8.665M |
| Debt to Equity Ratio | -3.456 |
| Current Ratio | 0.7452 |
| Net Debt Paydown Yield | 12.06% |